Roche Holding (Germany) Today
| RHO6 Stock | EUR 33.41 0.08 0.24% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Roche Holding is trading at 33.41 as of the 23rd of November 2024. This is a 0.24% increase since the beginning of the trading day. The stock's lowest day price was 32.92. Roche Holding has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Roche Holding Ltd are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of November 2023 and ending today, the 23rd of November 2024. Click here to learn more.
Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. ROCHE HLDG operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. The company has 6.39 B outstanding shares. More on Roche Holding Ltd
Moving against Roche Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Roche Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Roche Holding's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Roche Holding or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
Roche Holding Ltd (RHO6) is traded on Frankfurt Exchange in Germany and employs 103,613 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 217.1 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Roche Holding's market, we take the total number of its shares issued and multiply it by Roche Holding's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Roche Holding operates under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 6.39 B outstanding shares.
Roche Holding Ltd has accumulated about 12.34 B in cash with 20.98 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.81.
Check Roche Holding Probability Of Bankruptcy
Ownership AllocationRoche Holding owns a total of 6.39 Billion outstanding shares. Roughly 98.72 pct. of Roche Holding outstanding shares are held by general public with 1.28 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Roche Ownership Details
Roche Holding Risk Profiles
Although Roche Holding's alpha and beta are two of the key measurements used to evaluate Roche Holding's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.32 | |||
| Standard Deviation | 1.74 | |||
| Variance | 3.03 | |||
| Risk Adjusted Performance | (0.06) |
Roche Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Roche Holding without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Roche Holding Corporate Management
Elected by the shareholders, the Roche Holding's board of directors comprises two types of representatives: Roche Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Roche. The board's role is to monitor Roche Holding's management team and ensure that shareholders' interests are well served. Roche Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Roche Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Claudia Bockstiegel | G Counsel | Profile | |
| Barbara Schadler | Head Communications | Profile | |
| Johannes MD | Head Devel | Profile | |
| Bruno Eschli | Head Relations | Profile | |
| Thomas Schinecker | Chief Diagnostics | Profile | |
| Cristina Wilbur | Chief Officer | Profile | |
| William Anderson | Chief Pharmaceuticals | Profile |
Other Information on Investing in Roche Stock
Roche Holding financial ratios help investors to determine whether Roche Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Roche with respect to the benefits of owning Roche Holding security.